# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 5


For regulation 8 (amendment of Schedule 1 (further provisions for classification of medicinal products)) substitute—
“8. In Schedule 1—
(a) in paragraph 1—
(i) in sub-paragraph (b), insert “UK” before “marketing authorisation”;
(ii) in sub-paragraphs (e)(i), (f)(i) and (g)(i), for “marketing authorisation” substitute “UK marketing authorisation, EU marketing authorisation, Article 126a authorisation or parallel import licence”; and
(b) in paragraph 4, for “marketing authorisation” substitute “UK marketing authorisation, EU marketing authorisation, Article 126a authorisation, parallel import licence”.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/5 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.